| Literature DB >> 7477995 |
E Favale1, V Rubino, P Mainardi, G Lunardi, C Albano.
Abstract
We report an unblinded, open-label, add-on trial of fluoxetine, a selective serotonin reuptake inhibitor, in 17 patients with complex partial seizures with and without secondary generalization (mean follow-up duration, 14 +/- 1.1 months). Six patients showed complete disappearance of their daily seizures; in the others the seizure frequency was lowered by 30%. No patient reported side effects.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7477995 DOI: 10.1212/wnl.45.10.1926
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910